Free Trial

LENZ Therapeutics (LENZ) Earnings Date, Estimates & Call Transcripts

LENZ Therapeutics logo
$27.93
+0.97 (+3.60%)
(As of 11/1/2024 ET)

LENZ Therapeutics Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 6Before Market OpensConfirmed
Actual EPS
(Aug. 14)
-$0.40 Beat By $0.09
Consensus EPS
(Aug. 14)
-$0.49

LENZ Therapeutics announced Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.40, which beat analysts' consensus estimates of -$0.49 by $0.09. With a trailing EPS of $0.00, LENZ Therapeutics' earnings are expected to grow next year, from ($3.15) to ($2.85) per share.

LENZ Upcoming Earnings

LENZ Therapeutics' next earnings date is scheduled for Wednesday, November 6, 2024, with a conference call scheduled for at 8:00 AM ET. Interested parties can register for or listen to the call.

Get LENZ Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LENZ Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LENZ Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LENZ Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

LENZ Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.74-$0.51-$0.63
Q2 20243-$0.50-$0.41-$0.46
Q3 20243-$0.59-$0.45-$0.50
Q4 20243-$0.68-$0.47-$0.56
FY 202411-$2.51-$1.84-$2.14
Q1 20251-$0.55-$0.55-$0.55
Q2 20251-$0.81-$0.81-$0.81
Q3 20251-$1.10-$1.10-$1.10
Q4 20251-$0.77-$0.77-$0.77
FY 20254($3.23)($3.23)($3.23)

LENZ Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/6/2024
(Confirmed)
-------  
8/14/2024Q2 2024-$0.49-$0.40+$0.09-$0.40--
5/8/2024Q1 2024-$0.84-$3.53 -$2.69-$3.53--  
11/13/2023Q3 2023-$0.25-$0.19+$0.06$0.01--
8/14/2023Q2 2023-$0.31-$0.31-$0.35--
5/11/2023Q1 2023-$0.30-$0.38 -$0.08-$0.33--
3/20/2023Q4 2022-$0.51-$0.44+$0.07-$0.44--
11/9/2022Q3 2022-$0.49-$0.45+$0.04-$0.45--

LENZ Therapeutics Earnings - Frequently Asked Questions

LENZ Therapeutics has confirmed that its next quarterly earnings data will be published on Wednesday, November 6th, 2024. Learn more on LENZ's earnings history.

In the previous quarter, LENZ Therapeutics (NASDAQ:LENZ) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.49) by $0.09. Learn more on analysts' earnings estimate vs. LENZ's actual earnings.

LENZ Therapeutics (NASDAQ:LENZ) has a recorded net income of -$124.65 million. LENZ has generated $0.00 earnings per share over the last four quarters.

LENZ Therapeutics's earnings are expected to grow from ($3.15) per share to ($2.85) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:LENZ) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners